Indicator | EBG Treatment (commencement) | ED treatment, % use in study | In-patient treatment, % use in study |
---|---|---|---|
Drugs | Dose (commencement) | Â | |
Aspirin | 300 mg then 81 mg daily (Day 1) | 97.2 | 963(87.1) |
Clopidogrel | 300 mg then 75 mg daily (Day 1) | 97.2 | 964(87.2) |
Enoxaparin (Heparin) | 1 mg/kg twice daily (Day 1) | 81.3 | 80.6 |
ACE inhibitor/ARB | Initiate with low dose and titrate upwards (Day 1) | NA | 806(72.9) |
Beta blocker | Initiate with low dose and titrate upwards (Day 1) | 30.3 | 846(76.5) |
Statin | Night time max tolerated dose (Day 1) | NA | 913(82.5) |
Primary PCI | Not applicable (not a PCI center) | NA | NA |
Nitrates | As required | 15.0 | 809(73.1) |
Investigations | |||
 ECG | Daily (Day 1) at least 2 | 100.0 | NA |
 Cardiac enzymes | Daily (Day 1) at least 2 | 67.3 | 1106(100) |
 Echocardiogram | Prior to discharge | NA | 632(57.1) |
 EST | If necessary | NA | NA |
Risk stratification | |||
 TIMI or GRACE score or other | Within 24 h | NA | NA |
Surgical intervention | |||
 Early invasive NSTEMI | Intermediate- and high-risk patient: 24 to 48 h of admission | Nil | Nil |
 Late invasive NSTEMI | Low-risk patient: 25 to 72 h of admission | Nil | Nil |
Lifestyle counseling | |||
 Diet | Hospital stay | Nil | 4.8 |
 Smoking | Hospital stay | Nil | 1.9 |
 Exercise | Hospital stay | Nil | 1.3 |
 Daily activity | Hospital stay | Nil | 0.0–0.6 |
Cardiac rehab initiated | Hospital stay | Nil | 0.0 |
Discharge medication | Pharmacist review day 4 and before discharge | Nil | Nil |